Dyne Therapeutics Inc’s recently made public that its Director Kersten Dirk unloaded Company’s shares for reported $8.21 million on Aug 15 ’24. In the deal valued at $45.37 per share,180,891 shares were sold. As a result of this transaction, Kersten Dirk now holds 1,372,148 shares worth roughly $62.28 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Kersten Dirk sold 100,650 shares, generating $4,395,386 in total proceeds. Upon selling the shares at $43.67, the Director now owns 1,553,039 shares.
Before that, Kersten Dirk sold 133,985 shares. Dyne Therapeutics Inc shares valued at $5,731,742 were divested by the Director at a price of $42.78 per share. As a result of the transaction, Kersten Dirk now holds 1,653,689 shares, worth roughly $75.06 million.
Chardan Capital Markets reiterated its Dyne Therapeutics Inc [DYN] rating to a Buy in a research note published on May 21, 2024; the price target was $42. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. H.C. Wainwright began covering DYN with “Buy” recommendation on February 20, 2024. Raymond James revised its rating on February 27, 2023. It rated DYN as “a Strong buy” which previously was an “an Outperform”.
Price Performance Review of DYN
On Friday, Dyne Therapeutics Inc [NASDAQ:DYN] saw its stock fall -0.77% to $45.39. Over the last five days, the stock has gained 4.11%. Dyne Therapeutics Inc shares have risen nearly 241.28% since the year began. Nevertheless, the stocks have risen 329.83% over the past one year. While a 52-week high of $46.00 was reached on 08/16/24, a 52-week low of $6.40 was recorded on 01/03/24. SMA at 50 days reached $38.83, while 200 days put it at $25.35.
Levels Of Support And Resistance For DYN Stock
The 24-hour chart illustrates a support level at 44.13, which if violated will result in even more drops to 42.87. On the upside, there is a resistance level at 46.52. A further resistance level may holdings at 47.65. The Relative Strength Index (RSI) on the 14-day chart is 63.94, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.87, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 9.82%. Stochastics%K at 92.00% indicates the stock is a selling.
How much short interest is there in Dyne Therapeutics Inc?
A steep rise in short interest was recorded in Dyne Therapeutics Inc stocks on 2024-07-31, growing by 0.81 million shares to a total of 9.88 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 9.08 million shares. There was a rise of 8.15%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 15, 2023 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $34 price target.
